Cite
HARVARD Citation
Day, D. et al. (2020). Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck. Oral oncology. p. . [Online].